Related Experiment Video
Updated: Jul 10, 2026
03:19
Point-of-Care Kidney and Genitourinary Ultrasound in Adults: Image Acquisition
Published on: June 21, 2024
Obesity and the kidney: why is the kidney at risk?
1Department of Medicine, Harvard Medical School and Brigham and Women's Hospital, Boston, Massachusetts 02115, USA. djpagecapo@rics.bwh.harvard.edu
Kidney International
|January 26, 2007
Abstract:
Two recent studies may help to account for the increase in risk of renal injury associated with obesity. One study pointed to a role for renin-system activation. In the other study, the pattern of renal hemodynamics was compatible with a renin mechanism.
Insights
Obesity increases kidney injury risk, potentially due to the renin-angiotensin system. Recent studies suggest renin-system activation and specific renal hemodynamic patterns are linked to this increased risk in obese individuals.
Area of Science:
- Nephrology
- Endocrinology
- Cardiovascular Science
Background:
- Obesity is a growing global health concern linked to numerous complications.
- Renal injury is a significant comorbidity associated with obesity.
- The exact mechanisms underlying obesity-related renal injury require further elucidation.
Discussion:
- Two recent studies investigated the link between obesity and renal injury.
- One study highlighted the potential role of renin-system activation in this process.
- The second study's findings on renal hemodynamics were consistent with a renin-mediated mechanism.
Key Insights:
- Evidence suggests the renin-angiotensin system may play a crucial role in obesity-induced renal damage.
- Observed alterations in renal hemodynamics in obese individuals align with renin pathway involvement.
- These findings offer potential targets for preventing or treating kidney disease in obesity.
Outlook:
- Further research is needed to fully understand the renin system's contribution to renal injury in obesity.
- Investigating therapeutic interventions targeting the renin system could mitigate kidney damage.
- Longitudinal studies are warranted to confirm the causal relationship and clinical implications.
Related Concept Videos
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:21External Anatomy of the Kidney
The kidneys are a pair of bean-shaped organs in the human body that play a critical role in maintaining overall health. They filter out waste products from the blood, regulate blood pressure, maintain electrolyte balance, and stimulate the production of red blood cells.
The kidneys are located in the retroperitoneal space on either side of the vertebral column, protected posteriorly by the 11th and 12th ribs. The right kidney sits slightly lower than the left owing to the presence of the liver...
The kidneys are located in the retroperitoneal space on either side of the vertebral column, protected posteriorly by the 11th and 12th ribs. The right kidney sits slightly lower than the left owing to the presence of the liver...
01:21Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
01:25Chronic Kidney Disease I: Introduction
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...